The historical rank and industry rank for Mira Pharmaceuticals's Net Margin % or its related term are showing as below:
MIRA's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.53 * Ranked among companies with meaningful Net Margin % only.
Mira Pharmaceuticals Net Margin % Historical Data
The historical data trend for Mira Pharmaceuticals's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mira Pharmaceuticals's Net Margin %
For the Drug Manufacturers - General subindustry, Mira Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mira Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mira Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Mira Pharmaceuticals's Net Margin % falls into.
Mira Pharmaceuticals Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Mira Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mira Pharmaceuticals (NAS:MIRA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mira Pharmaceuticals Net Margin % Related Terms
Thank you for viewing the detailed overview of Mira Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Mira Pharmaceuticals (Mira Pharmaceuticals) Business Description
Mira Pharmaceuticals Inc is an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Its target patient population is also typically presenting with chronic pain. its drug candidate, MIRA1a, if approved by the FDA, maybe a significant advancement in the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders. Based on pre-clinical and animal studies conducted by the company, it believes that MIRA1a enhances the therapeutic potential for treating anxiety, cognitive decline and chronic pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MIRA has been successfully added to your 